INTRODUCTION
============

The intestinal epithelial barrier is created by a series of intercellular transmembrane adhesion and cytosolic protein complexes that form the apical junctional complex (AJC) consisting of the tight junction (TJ) and the adherens junction (AJ) ([@B18]; [@B37]). Additionally, spot-like adhesions or desmosomes (DMs) residing subjacent to the AJC, contribute to controlling intercellular adhesion strength and epithelial homeostasis. The extracellular adhesive core in DMs is formed by the desmosomal cadherins desmoglein (Dsg) and Desmocollin (Dsc), which are single-pass transmembrane glycoproteins of the cadherin superfamily and calcium-dependent anchoring junctions. Four Dsg and three Dsc isoforms (Dsg 1--4 and Dsc 1--3) are expressed in a tissue-specific and differentiation-specific manner. DM cadherins engage in a homo- or heterophilic manner and are internally linked to intermediate filament cytoskeleton through specific desmosomal plaque proteins including plakoglobin, plakophillins, and desmoplakin ([@B25]; [@B47]). DMs are highly enriched in tissues that experience extensive mechanical stress, such as cardiac muscle and epidermis as well as in the intestinal mucosa. Abnormal desmosomal function or disruption of desmosomal assembly causes several human pathologies comprising autoimmune diseases pemphigus vulgaris and pemphigus foliaceus, cardiomyopathy, epidermal and mucosal blistering, and cancer progression ([@B11]; [@B74]; [@B8]; [@B26]; [@B44]).

Epithelial barrier properties are critical in maintaining intestinal mucosal homeostasis, and a breach in this barrier results in pathological states that are associated with excessive exposure to microbial antigens, recruitment of leukocytes, release of soluble mediators, and ultimately mucosal damage seen in inflammatory bowel diseases (IBD). IBD pathogenesis that encompasses Crohn's disease (CD) and ulcerative colitis (UC), two main forms of chronic relapsing intestinal inflammation, is not well understood ([@B3]; [@B53]). However, there is growing evidence that compromised intestinal barrier function plays a critical role in the epithelial damage and perpetuation of mucosal inflammation (inflammatory flares) by the recruitment of leukocytes into the subepithelial space that creates a local milieu enriched in soluble pro- and anti-inflammatory mediators that modulate epithelial barrier function ([@B20]; [@B9]; [@B48]). Furthermore, mucosal wound healing that is achieved by collective epithelial cell migration and proliferation is important to restore the epithelial barrier and suppress inflammatory responses ([@B49]; [@B54]; [@B7]; [@B57]).

Of note, intestinal epithelial cells (IEC) exclusively express Dsg2 and Dsc2 that have distinct binding properties and function in desmosome organization and adhesion. Dsc2 is reported to form homophilic bonds and heterophilic interactions with Dsg2, whereas Dsg2 engages only in heterophilic interactions ([@B63]; [@B52]; [@B69]; [@B39]). Dsc2 has been reported to play a major role in initiating desmosome assembly, whereas Dsg2 stabilizes the desmosomal complex ([@B61]; [@B10]; [@B39]). While Dsg2 has been reported to contribute to the intestinal epithelial barrier function, the role of DM cadherins in orchestrating in vivo repair of simple epithelia such as the intestinal epithelium remains undefined. Using predominantly in vitro models, we and others have observed that Dsg2 regulates intestinal epithelial proliferation and apoptosis ([@B46]; [@B64]; [@B73]; [@B77]). Conversely, the contributions of Dsc2 in controlling these cellular functions of simple epithelia remains less well understood. Loss of Dsc2 has been reported to promote IEC proliferation and colorectal cancer development ([@B19]; [@B36]). Interestingly, the expression of both, Dsg2 and Dsc2 is reduced in patients with CD, suggesting a role for Dsg2 and Dsc2 in the pathogenesis of inflammatory diseases in the intestine ([@B68]; [@B23]). Recently, it has been reported that stable IEC-specific Dsg2 knockdown (KD) driven by the *Villin* promoter resulted in increased intestinal permeability in vivo and enhanced sensitivity to dextran sulfate sodium (DSS) as well as *Citrobacter rodentium*--induced colitis ([@B23]). Surprisingly, IEC-specific KD of Dsc2 showed a lack of notable phenotype on intestinal epithelial barrier function in vivo and did not alter susceptibility to DSS-­induced intestinal injury compared with control mice ([@B23]). These findings do not correlate with in vitro studies suggesting a major role for Dsc2 in desmosome biology ([@B61]; [@B10]; [@B39]).

To determine the role of Dsc2 in orchestrating intestinal mucosal repair after injury in vivo, we generated mice that harbor tamoxifen-inducible conditional KD of Dsc2 in IEC (*Villin*-Cre^ERT2^; *Dsc2*^fl/fl^, or *Dsc2*^ERΔIEC^). In this model, Dsc2 is acutely deleted in the adult mouse intestine, thereby serving as a model to analyze its role in epithelial repair. We describe the effect of KD of Dsc2 in two distinct models of epithelial injury and repair, namely, DSS-induced epithelial injury followed by a recovery period by discontinuation of DSS administration and colonic mucosal biopsy-induced wounds. Mechanistic analysis of the contribution of Dsc2 in intestinal epithelial repair after injury was conducted in vitro using human IEC lines. Herein we report that Dsc2 regulates intestinal mucosal wound closure by controlling cell--matrix adhesion dynamics and IEC migration.

RESULTS AND DISCUSSION
======================

Targeted deletion of Dsc2 in IEC does not influence baseline intestinal mucosal architecture
--------------------------------------------------------------------------------------------

To explore the contribution of Dsc2 in IEC biology and mucosal repair after injury, we generated *Dsc*2^ERΔIEC^ mice that express an ERT2-Cre fusion protein under control of *Villin* promoter ([@B15]). Tamoxifen treatment resulted in acute selective deletion of Dsc2 in IEC that was confirmed in the colon from *Dsc*2^ERΔIEC^ versus *Dsc*2^fl/fl^ control littermate mice by immunofluorescence (IF) labeling and Western blot analyses 30 d after tamoxifen administration ([Figure 1, A and B](#F1){ref-type="fig"}). Consistent with a previous report, we found that acute loss of Dsc2 on IEC in vivo did not alter the protein levels of either Dsg2 or E-cadherin ([Figure 1B](#F1){ref-type="fig"}) ([@B23]). Furthermore, histologic analysis of colonic mucosa in *Dsc*2^ERΔIEC^ mice 30 d after tamoxifen treatment revealed no signs of colitis. The mucosa had normal architecture with no gross abnormalities or signs of immune cell infiltration and was indistinguishable from littermate controls ([Figure 1, C and D](#F1){ref-type="fig"}). These results suggested that selective loss of Dsc2 on IEC does not grossly alter intestinal mucosal homeostasis.

![Selective loss of Dsc2 in IEC does not cause intestinal inflammation at baseline. *Dsc2*^ERΔIEC^ mice were treated with tamoxifen to induce acute deletion of Dsc2 in IEC and analyzed 4 wk after the last tamoxifen injection. (A) Representative images of colon tissue stained with anti-Dsc2 antibodies (green) and DAPI (nuclei/blue). Dsc2 expression is absent in the colonic epithelium in *Dsc2*^ERΔIEC^ mice compared with control *Dsc2*^fl/fl^ mice. Scale bars: 50 μm. (B) Whole colonic tissue was homogenized, proteins were separated by SDS--PAGE, and PVDF membrane was immunoblotted for Dsc2, Dsg2, E-cadherin, and β-actin. Numbers 1--3 represent individual mice. (C, D) Representative images of H&E staining of section of Swiss roll mounts of the entire colon showing the gross mucosal architecture of *Dsc2*^ERΔIEC^ vs. *Dsc2*^fl/fl^ mice. No signs of alteration of the epithelial barrier nor intestinal inflammation in *Dsc2*^ERΔIEC^ (D) in comparison to control mice (C). Scale bars: 200 μm.](mbc-31-407-g001){#F1}

Down-regulation of Dsc2 in human UC individuals and mouse colitis
-----------------------------------------------------------------

It has been reported that patients with CD have altered ultrastructure of DMs by electron microscopy and have reduced expression of intestinal epithelial Dsg2 and Dsc2 ([@B68]). In one study, decreased expression of colonic Dsc2 was observed in individuals with UC ([@B20]). Therefore, we evaluated expression of Dsc2 in the intestinal mucosa of individuals with UC by IF labeling and immunoblotting and found that Dsc2 protein was decreased in mucosal tissue of individuals with active UC compared with mucosa without active disease ([Figure 2, A and B](#F2){ref-type="fig"}). Similarly, expression of Dsc2 was reduced in the inflamed colon of mice with DSS-induced mucosal injury ([Figure 2, C and D](#F2){ref-type="fig"}). Interestingly, we also detected reduced expression of low molecular weight cleavage fragments of Dsc2 in inflamed colon from individual with active UC and murine colitis.

![Dsc2 is decreased in human and mouse inflamed colon, and its loss resulted in delayed mucosal recovery from colitis. (A) Representative images of IF staining of Dsc2 (green) and DAPI (blue) in frozen sections of human colonic tissues from patients with UC and healthy controls. Reduction of fluorescence intensity for Dsc2 in UC compared with control. Scale bars: 50 μm. (B) Western blot (WB) and densitometry analysis of the expression of Dsc2 and loading control Cytokeratin-8 (CK-8) in human colonic tissues from patients with UC and healthy controls. WB images are representative of two individual experiments with 10 controls and nine UC samples. Arrowhead: Full-length Dsc2; asterisk: cleaved Dsc2. Bar graphs represent densitometric values of seven healthy controls and six UC samples and are normalized to control. Data are mean ± SEM. Significance is determined by two-tailed Student's *t* test. \**p* ≤ 0.05. (C, D) Reduced expression of Dsc2 in inflamed colonic mucosa from DSS-treated wild-type C57BL/6 mice at day 7 of DSS treatment (5 d DSS followed by 2 d of water) by IF and WB. (C) Representative IF images of frozen sections of colon tissue from DSS-treated mice vs. untreated controls. Dsc2 (green) and DAPI (blue). Reduction of fluorescence intensity for Dsc2 in DSS compared with control. Scale bars: 50 μm. (D) Representative WB images and densitometry analysis of the expression of Dsc2 and CK-8 in colon from DSS-treated mice vs. untreated controls. Arrowhead: Full-length Dsc2; asterisk: cleaved Dsc2. Bar graphs represent values of three individual mouse per group and normalized to controls. Data are mean ± SEM. Significance is determined by two-tailed Student's *t* test. \**p* = 0.04. (E--H) Age- and sex-matched *Dsc2*^ERΔIEC^ and littermate control (*Dsc2*^fl/fl^) mice were used 4 wk after the last tamoxifen injection and then subjected to DSS-induced colitis by administration of 2.5% DSS for 5 d followed by regular drinking water for 5 d to promote mucosal recovery. *Dsc2*^ERΔIEC^ are more susceptible to colitis and present delayed recovery from colitis, as reflected by (E) significantly greater body weight loss and (F) higher values of DAI, compared with *Dsc2*^fl/fl^ mice. (E, F) Data are combined values of three independent experiments (30 mice per group) and are expressed as mean ± SEM. Significance is determined by two-way ANOVA. \*\*\**p* ≤ 0.001. (G) Representative images of H&E staining of section of Swiss roll mounts of the distal colon of *Dsc2*^ERΔIEC^ mice compared with controls at day 10. Scale bars: 200 μm. (H) Percentage of injury/ulceration that represents the ratio of the length of injured/ulcerated areas (≥50% crypt loss) relative to the entire colon length showing more mucosal ulcerations in *Dsc2*^ERΔIEC^ mice compared with controls. Dots represent individual mice. Data are combined from three independent experiments (14--15 mice per group) and expressed as mean ± SEM. Significance is determined by two-tailed Student's *t* test. \*\**p* = 0.003.](mbc-31-407-g002){#F2}

Of note, studies from our laboratory and others have demonstrated the existence of proteolytic cleavage fragments of human Dsg2 caused by matrix metalloproteinases, caspases, and a disintegrin and metalloproteinase (ADAM) ([@B46]; [@B12]; [@B36]). Proinflammatory cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) released into the epithelial milieu during mucosal inflammation result in increased cleavage fragments of Dsg2 and ectodomain shedding from IEC in the intestinal mucosa from patients with active UC and in the mucosa of mice with DSS-induced colitis. These fragments have biological effects on cellular processes including proliferative signaling in epithelial cells, cell adhesion, and apoptosis ([@B64]; [@B45]; [@B32]; [@B77]).

Interestingly, here we show that unlike Dsg2, the decrease in full-length Dsc2 protein did not appear to be related to accumulation of its proteolytic cleavage fragments in the intestinal mucosa of individuals with UC and in murine colitis. Furthermore, given that numerous reports have described that proinflammatory cytokines result in down-regulation of intercellular junction proteins of TJ, AJ, and DMs, it is tempting to speculate that proinflammatory mediators may control the expression of Dsc2 in IEC via distinct mechanisms compared with those that control Dsg2 ([@B40]). Further studies are needed to determine the molecular mechanisms involved in the down-regulation of Dsc2 expression.

Delayed recovery from acute colitis in mice with Dsc2 KD in IEC
---------------------------------------------------------------

We further examined the physiological role(s) of Dsc2 in mucosal responses to acute injury and repair using a murine model employing acute DSS-induced mucosal injury followed by recovery. *Dsc*2^ERΔIEC^ mice and *Dsc*2^fl/fl^ littermate controls were treated with DSS in drinking water for 5 d followed by a recovery period without DSS in water to evaluate mucosal recovery. During the recovery period, *Dsc*2^ERΔIEC^ mice exhibited an exacerbated increased body weight loss compared with control mice ([Figure 2E](#F2){ref-type="fig"}). Mice with \>20% of body weight loss were killed and quantified in the Kaplan Meier survival curves (Supplemental Figure S1A). Eighty percent of *Dsc*2^fl/fl^ control mice survived in the course of the experiment and recovered from DSS-induced injury at day 10 in comparison to 44.5% of *Dsc*2^ERΔIEC^ mice. These observations revealed that selective loss of Dsc2 on IEC resulted in increased morbidity and mortality during recovery from DSS colitis. Analysis of disease activity index (DAI), representing a score incorporating weight loss, stool consistency (diarrhea), and blood in stools similarly demonstrated poor recovery in *Dsc*2^ERΔIEC^ mice compared with controls ([Figure 2F](#F2){ref-type="fig"}). The elevated DAI scores also paralleled enhanced colon shortening after DSS, further supporting other parameters of mucosal inflammation in *Dsc*2^ERΔIEC^ mice (Supplemental Figure S1B). Histological analysis of colonic mucosa 5 d after recovery from colitis revealed significantly worse mucosal injury in *Dsc*2^ERΔIEC^ mice. Mucosal ulceration (crypt loss) was confined to the distal colon in *Dsc*2^fl/fl^ control mice, while *Dsc*2^ERΔIEC^ mice had extensive ulcers that extended into the mid colon ([Figure 2, G and H](#F2){ref-type="fig"}).

The above findings are at odds with a recent report that used constitutive deficient *Villin*-Cre; *Dsc2*^fl/fl^ and observed no consequences of loss of Dsc2 on IEC in the progression of DSS-induced colitis in comparison to control mice ([@B23]). Herein, a major difference is that we used animals with acute deletion of Dsc2 in IEC in adult mice that diminishes compensatory responses with other cadherins that have been reported for the loss of Dsg2 that resulted in up-regulation of Dsc2 in vivo and in vitro ([@B31]; [@B23]). Furthermore, in their experimental model, Gross *et al.* reported that loss of Dsc2 resulted in upregulation of Dsg-2-binding protein Galectin-3 in Dsc2-deficient mice ([@B23]). In this study, Galectin-3 was suggested to compensate for the Dsc2 loss in IEC and account for the lack of phenotype seen in the intestinal mucosa Dsc2-deficient mice. We have previously reported that Galectin-3 associates with the ectodomain of Dsg-2 and stabilizes Dsg-2 at the cell surface leading to enhanced intercellular adhesion ([@B30]).

Taken together, our results show that acute loss of intestinal epithelial Dsc2 resulted in impaired epithelial recovery from DSS-induced injury indicating a protective role of Dsc2 in intestinal mucosal repair.

Delayed colonic mucosal wound healing after Dsc2 loss
-----------------------------------------------------

To further examine the contribution of Dsc2 in intestinal mucosal repair, a second model of injury and repair was utilized that employs miniaturized endoscopic biopsy-induced wounds in the distal colon. Wound closure was quantified by digital imaging of the same wounds. *Dsc*2^ERΔIEC^ mice exhibited significantly reduced wound repair 3 d after biopsy-induced injury compared with *Dsc*2^fl/fl^ controls supporting a role of Dsc2 in intestinal mucosal repair ([Figure 3, A and B](#F3){ref-type="fig"}). IF labeling of epithelial E-cadherin in frozen sections of healing wounds was used to identify wound associated epithelial cells. Whereas the wound-associated epithelium was observed to cover wound beds in the *Dsc*2^fl/fl^ colonic mucosa, the *Dsc*2^ERΔIEC^ colon wound bed was exposed with few E-cadherin expressing wound-associated epithelial cells covering denuded surfaces. These findings support impaired epithelial wound repair in the absence of IEC Dsc2 ([Figure 3C](#F3){ref-type="fig"}).

![Loss of Dsc2 in IEC resulted in impaired colonic mucosal healing after biopsy-induced wound injury. (A) Representative endoscopic images of biopsy-induced colonic wounds at 24 and 72 h postinjury in *Dsc2*^ERΔIEC^ and *Dsc2*^fl/fl^ mice. (B) Digital measurement of wound surface at 24 and 72 h postwounding revealed significant impairment of wound healing in absence of Dsc2 on IEC. Scale bar: 50 μm. Dots represent the mean value within three to five wounds from individual mice. Data are combined values of two independent experiments with 12--15 mice per group and are expressed as mean ± SEM. Significance is determined by two-tailed Student's *t* test. \*\*\**p* ≤ 0.001. (C) IF images of frozen sections of wound beds at 72 h postinjury stained with the epithelial marker E-cadherin (green) and DAPI (blue) showing a dramatic impairment of wound closure in *Dsc2*^ERΔIEC^ mice. *Dsc2*^fl/fl^ mice present a layer of wound-associated epithelial cells that covers the wound that is absent in *Dsc2*^ERΔIEC^ mice. (D) Ki67 staining (magenta) and DAPI counterstain (blue) of frozen sections of crypts immediately adjacent to wound beds at 72 h postinjury revealed similar proliferation rate between *Dsc2*^ERΔIEC^ and *Dsc2*^fl/fl^ mice. C and D show representative IF images of five mice per group. Scale bar: 100 μm.](mbc-31-407-g003){#F3}

Since efficient epithelial wound healing requires cell proliferation as well as coordinated collective migration of cells, we examined the effect of Dsc2 loss on IEC proliferation in vivo after biopsy-induced injury. Proliferation of epithelial cells adjoining the wound bed was evaluated by IF labeling of the well-accepted cell proliferation marker Ki67. Cell proliferation in crypts adjacent to the wound bed was not compromised after KD of Dsc2 in IEC ([Figure 3D](#F3){ref-type="fig"}), suggesting that delayed wound closure after Dsc2 KD was not due to impaired epithelial cell proliferation. Altogether, our results suggest that the impaired repair is likely due to defective epithelial cell migration.

Dsc2 deficiency impairs epithelial--extracellular matrix adhesion
-----------------------------------------------------------------

To get further insight into the molecular basis of delayed wound closure in IEC lacking Dsc2 in vivo, we utilized the human model IEC line SKCO15 transfected with short-hairpin RNA (shRNA) for acute KD of Dsc2 versus scramble nonsilencing control ([Figure 4A](#F4){ref-type="fig"}). Epithelial cell monolayers were subjected to scratch-wound healing assays that revealed delayed epithelial wound closure in cells with Dsc2 KD ([Figure 4B](#F4){ref-type="fig"}). Expression of Dsg2 is not perturbed by Dsc2 loss ([Figure 4A](#F4){ref-type="fig"}), suggesting that Dsc2 directly impacts intestinal mucosal wound repair independent of Dsg2. These findings confirm a role of Dsc2 in promoting IEC migration in response to wound injury in vitro and corroborate the above in vivo findings. In line with our observations, desmosomal proteins (including Dsc2, Dsg2, Dsg3, and Plakophilin-2) have been reported to control cell migration in vitro of keratinocytes and cancer cells such as human oral squamous carcinoma cell line or melanoma cells. However, these studies have not revealed consistent results in different cell types and model systems ([@B67]; [@B76]; [@B71]; [@B17]; [@B35]; [@B55]; [@B1]; [@B62]; [@B4]). Here, our results show that Dsc2 promotes intestinal epithelial restitution and wound repair.

![Loss of Dsc2 results in impaired wound closure and cell--matrix adhesion in vitro. SKCO15 cells were transduced with Dsc2-specific shRNA (Dsc2 KD) or with a nontargeting shRNA (control). (A) KD of Dsc2 expression was confirmed in SKCO15 by Western blot using anti-Dsc2 antibodies and anti-calnexin as loading control. No major changes were detected in the expression of Dsg2 in the absence of Dsc2. (B) Monolayers of SKCO15 cells were scratch-wounded and monitored for wound closure. Dsc2 KD cells showed significant delayed wound repair compared with control cells. Representative images of wounds at 0 and 18 h. Graph is representative of two independent experiments with three replicates per group and with two independently transduced SKCO15 cell culture. Data are mean ± SEM. Significance is determined by two-way ANOVA. \*\*\**p* ≤ 0.001. (C) Measurement of traction forces as well as cluster area within SKCO15 cell KD for Dsc2 (Dsc2 KD) or control cells by using fibronectin-coated microfabricated postarray detectors (mPADs) (see *Materials and Methods*). Representative images show posts (white) with the cell cluster outlined in blue and force vectors (green) calculated from post deflections. Total traction force represents the sum of the magnitudes of the force vectors for each cell cluster. Data consists of 20 cell clusters per condition and are representative of two independent experiments with two independently transduced SKCO15 cell culture. Significance is determined by two-tailed Student's *t* test. \*\*\**p* ≤ 0.001. Scale bars: 5 μm. Scale for force: 10 nN.](mbc-31-407-g004){#F4}

The importance of mechanical coupling between cells has been documented for diverse multicellular processes, including collective migration during wound healing. Collective migration of epithelial cells during repair requires coordinated modification of cell--cell and cell--matrix adhesive contacts, cytoskeletal restructuring, and cellular protrusions that serve in concert to generate propulsive traction forces ([@B70]). To assess the effects of Dsc2 expression on cell adhesive force generation, we used microfabricated post array detectors (mPADs) to measure cell-generated forces during cell adhesion to the extracellular matrix. When seeded overnight onto fibronectin-coated mPADs, cells spread and formed multicellular clusters and the data represent a "snapshot" of traction forces in a cell cluster at equilibrium after overnight culture. An image of a cell cluster is outlined in blue and force vectors in green were calculated from post deflections ([Figure 4C](#F4){ref-type="fig"}). The magnitude of traction forces varied across cell clusters with the highest values occurring at the periphery of migrating cell groups. A plot of total traction force represents a sum of the magnitudes of force vectors of each cell cluster periphery. Such analyses have previously been used to map exchange of mechanical forces at cell--cell adhesion sites and to measure strength of forces exchanged between cells across clusters of multiple cells ([@B50]). We measured post deflections for control and Dsc2 KD cell clusters using SKCO15 cells and detected smaller clusters for Dsc2 KD cells compared with cells expressing Dsc2 ([Figure 4C](#F4){ref-type="fig"}). Furthermore, SKCO15 cell clusters lacking Dsc2 displayed a dramatic defect in traction force generation compared with the control cells. Similarly, KD of Dsc2 in another IEC line, Caco-2BBE revealed a defect in the traction force generation compared with the control cells (Supplemental Figure S2). However, epithelial cell cluster area in control and Dsc2 KD cells were not different (Supplemental Figure S2). Collectively, these findings demonstrate that Dsc2 plays an important role in controlling cell--cell and cell--matrix adhesions and suggest that loss of Dsc2 results in decreased mechanotransduction between IEC and extracellular matrix that leads to impaired downstream signaling pathways and impaired IEC migration. In line with our findings, E-cadherin has been reported to influence cell--matrix mechanics that regulate traction stress generation and distribution that influences epithelial cell migration ([@B51]; [@B43]). Another desmosomal protein, Plakoglobin, has been reported to play a role in formation of polarized protrusion and keratin cytoskeleton rearrangement after application of force to *Xenopus* mesendoderm cells that results in coordinate changes in cell protrusive behavior required for collective cell migration ([@B75]).

Dsc2 regulates the expression of integrins and Ras-related protein 1 (Rap1) activity
------------------------------------------------------------------------------------

Transmembrane integrin proteins serve as vital regulators and mediators of cell--matrix adhesion and are key players in controlling epithelial cell migration and wound healing ([@B28]; [@B27]; [@B33]). Integrins α2β1 (collagen and laminin receptor) and α6β4 (component of hemidesmosome and laminin receptor) have been reported by us and others to regulate epithelial wound healing ([@B38]; [@B6]; [@B22]; [@B42]; [@B59]). We therefore evaluated the effect loss of Dsc2 on expression of these integrins in migrating SKCO15 cells. Immunoblot analysis (WB) revealed that lack of Dsc2 resulted in decreased protein expression of integrin subunits α2, α6, β1, and β4 ([Figure 5, A and B](#F5){ref-type="fig"}) but not corresponding mRNA (Supplemental Figure S3), implying a posttranscriptional change in integrin proteins after Dsc2 KD. These findings suggested functional interplay between desmosomal cadherins and integrin β1 and β4. Indeed, it has been reported that Dsg2 can directly interact with integrin β8 to promote endothelial cells angiogenesis but there is no evidence of an interaction in IEC ([@B21]). Our findings are in line with reports demonstrating a functional interplay between E-cadherin and α2β1 integrin to regulate epithelial cell migration ([@B5]; [@B66]). Furthermore, we have described that other junctional adhesion molecules, such as TJ-associated protein junctional adhesion molecule-A (JAM-A) ([@B65]) and basolateral membrane protein CD47 ([@B60]), regulate the expression/stability of integrin β1, whereas there is no evidence of direct interaction. Whether Dsc2 interacts physically with integrin β1 and β4 or regulates stability of these proteins by indirect mechanisms needs further investigation.

![Dsc2 controls the expression of integrins, Pkp3 and Rap1 activity in vitro. (A, B) Loss of Dsc2 in SKCO15 cells results in reduced expression of beta 1 and beta 4 integrins. (A) Whole cell lysates from subconfluent monolayer of SKCO15 KD for Dsc2 (Dsc2 KD) or control cells were subjected to SDS--PAGE and immunoblot against Dsc2 and integrin subunits alpha 2, alpha 6, beta 1, and beta 4. Calnexin was used as loading control. Western blot images are representative of four independent experiments. (B) Histograms represent densitometric values normalized to controls from four independent experiments with independently transduced SKCO15 cell culture. Bar graphs are mean ± SEM. Significance is determined by two-tailed Student's *t* test. \*\*\**p* ≤ 0.001, \**p* = 0.05. (C, D) Loss of Dsc2 resulted in pull down of less active Rap1 in comparison to control cells. (C) Subconfluent monolayers of SKCO15 KD for Dsc2 (Dsc2 KD) or control cells were subjected to RalGDS pull down followed by SDS--PAGE. GTP-bound Rap1 was detected by Western blotting with anti-Rap1 antibodies. Densitometric quantification of immunoblots of active Rap1 by RalGDS pull down normalized to control. (D) Pkp3 was evaluated in whole cell lysates of SKCO15 KD for Dsc2 (Dsc2 KD) or control cells. Densitometric quantification of immunoblots of Plakophilin 3 normalized to control. (C, D) WB images are representative of three independent experiments with independently transduced SKCO15 cell culture. Bar graphs are mean values from three independent experiments ± SEM. Significance is determined by two-tailed Student's *t* test. \*\**p* = 0.01. (E) Model summarizing the role of intestinal epithelial-expressed Dsc2 in mucosal repair after injury. Dsc2 regulates intestinal mucosal wound closure by controlling integrin expression, cell--matrix adhesion dynamics and cell migration. Top panel depicts baseline condition with IEC expressing Dsc2 (red) and Dsg2 (blue) forming mature Desmosome (DM) complexes that promote cell cohesion and contribute to collective migration and wound healing. Signaling pathways downstream of DM in parallel to those from the AJC activate the small GTPase Rap1 influencing integrin function, thereby promoting cell adhesion to the extracellular matrix (ECM) and cell migration. Bottom panel shows the consequences of Dsc2 absence on IEC that results in reduced expression of Pkp3. Loss of Dsc2 is also associated with reduced cell cohesion, decreased levels of integrin β1 and β4, and reduced activity of Rap1. AJ, adherens junction; DP, Desmoplakin, IF, intermediate filaments; Integrins are depicted as αβ complexes; PG, Plakoglobin; TJ, tight junction.](mbc-31-407-g005){#F5}

To gain further insight into the molecular basis of regulation of cell migration by Dsc2, we investigated the involvement of small GTPases family members that have been reported to regulate cell--matrix interactions, integrin function, and intestinal barrier function ([@B13]). Surprisingly, among the Rho family of GTPases (including RhoA, Rac1, and Cdc42), we did not observe significant changes in their activity in response to Dsc2 KD in IEC (unpublished data). Therefore, we next determined Rap1 GTPase activity that has been linked to intercellular adhesion molecules and β1 integrin activation in epithelial cells ([@B34]). Furthermore, we have previously reported that the complex JAM-A/Rap1 regulates integrin levels in epithelial cells ([@B41]) and others have observed that the desmosomal protein Plakophilin-3 (Pkp3) forms a complex with the Rap1 GTPase, promoting its activation and facilitating desmosome assembly and AJ maturation ([@B24]; [@B72]). Analysis of Rap1 activation revealed decreased Rap1 activity after Dsc2 KD ([Figure 5C](#F5){ref-type="fig"}). Interestingly, we detected reduced expression of Pkp3 in Dsc2 KD cells in comparison to control cells ([Figure 5D](#F5){ref-type="fig"}), suggesting that Pkp3 may control Rap1 activity, as previously reported in keratinocytes ([@B72]). All together, these findings suggest a signaling axis among Dsc2, Rap1, and integrins β1 and β4 that orchestrates IEC migration and wound closure ([Figure 5E](#F5){ref-type="fig"}). It is plausible that Dsc2 indirectly controls Rap1 activity through Pkp3. However, we cannot exclude the involvement of other signaling pathways that have been reported to activate Rap1 and promote barrier function such as EPAC (guanine exchange factor \[GEF\] protein directly activated by cAMP), a main GEF for Rap1 ([@B72]; [@B58]).

In conclusion, our findings demonstrate that expression of desmosomal cadherin Dsc2 in IEC regulates intestinal mucosal wound closure. Furthermore, Dsc2 controls transduction of force from the enterocytes to the extracellular matrix through modulation of integrin β1and β4 proteins as well as Rap1 activity that orchestrates effective cell migration and wound healing.

MATERIALS AND METHODS
=====================

Mice
----

Mice with selective Dsc2 deficiency in IEC were generated on a C57Bl/6 background by breeding *Dsc2* floxed mice (*Dsc2*^f/f^) with mice expressing the inducible mutated estrogen receptor fused to Cre-recombinase under control of the *Villin* promoter: *Villin*-Cre^ERT2^; *Dsc2*^fl/fl^ (*Dsc2*^ERΔIEC^). Mice were bred in-house at the University of Michigan (Ann Arbor, MI) and kept under strict specific pathogen-free conditions with ad libitum normal chow and water. Eight-week-old *Dsc2*^ERΔIEC^ and control littermates *Dsc2* ^f/f^ mice were injected intraperitoneally (i.p.) with 1 mg/100 μl of tamoxifen (T5648, Sigma) dissolved in sterile corn oil (C8267, Sigma) for 5 consecutive days. Animals were used 4 wk after the last tamoxifen injection. All experiments were approved and conducted in accordance with guidelines set by the University of Michigan Institutional Animal Care and Use Committee.

Cell culture
------------

SKCO15 and Caco-2BBE human model of IEC were grown in high glucose (4.5 g/l) DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 15 mM HEPES (pH 7.4), 2 mM [l]{.smallcaps}-glutamine, and 1% nonessential amino acids on tissue culture-treated plastic as previously described ([@B29]; [@B36]). Knockdown of Dsc2 was established by RNA interference using shRNA targeting Dsc2. Control cells were transduced with a scramble nonsilencing vector ([@B36]). A shRNA transduction (MOI of 2) of IEC was performed in 60--70% confluent IEC using spinfection method (1200 × *g* for 30 min at RT) followed by puromycin selection (1 μg/ml).

Antibodies and reagents
-----------------------

The following primary monoclonal and polyclonal antibodies were used to detect proteins by IF or WB: mouse anti-human/mouse Dsg-2 (clone AH12.2; WB:1/1000, IF: 1/100) was generated in-house ([@B46]). From Abcam: Ki67 (ab15580; IF:1/250), anti-integrin alpha 2 (ab133557; WB:1/1000), anti-integrin alpha 6 (ab181551; WB:1/1000) and cytokeratin 8 (ab53280; WB:1/40,000), and anti-mouse Pkp3 (ab151401; WB:1/1000). From BD Transduction Laboratories: anti-integrin alpha 4 (Cat. 611233). From Millipore: anti-active Rap1 (Cat. 07-916). From R&D systems: anti-human/mouse E-cadherin (AF748; WB: 1/2000; IF: 1/500), anti-mouse Dsc2 (AF7490; WB:1/500; IF: 1/200), and anti-integrin beta 1 (AF1778; WB: 1/1000). From Sigma: anti-beta actin (A2228; WB:1/5000). From Thermofisher: anti-human Dsc2 (Cat. 326200; WB: 1/1000; IF:1/250).

DSS treatment
-------------

Mice were provided with 2.5% wt/vol DSS (40--50 kDa, 14489, Affymetrix) dissolved in the drinking water ad libitum for 5 d followed by 5 d with normal drinking water. Clinical disease assessment was obtained daily, with scores of 0--4 assigned for body weight loss, stool consistency, and presence of blood in stools (Hemoccult, Beckman Coulter). The individual scores were added and the average was recorded as the DAI. Higher values of DAI reflect increasing severity of colitis. At the end of the experiment, mice were killed and colon length measured. Hematoxylin-eosin (H&E) staining of sections of Swiss roll mounts of the entire colon (8 μm thick) was performed to quantify colonic mucosal injury ([@B60]). Percentage of ulceration was calculated as a ratio of the length of injured/ulcerated area (≥50% crypt loss) relative to the entire colon length. Mice were humanely killed before the end of the experiment when weight loss reached more than 20% of the starting body weight, and the Kaplan-Meier method was used to draw the survival curve.

Wound healing assays
--------------------

For in vitro experiments, Dsc2 shRNA transduced SKCO15 cell monolayers or control cells were cultured on 24-well tissue culture plates to confluency and scratched using a 10 μl pipette tip under suction as we described previously ([@B2]). Monolayers were washed to remove cellular debris and medium was changed. Video quantification of scratch-wound closure was performed by imaging wounds at 30-min intervals in an Axiovert Observer live cell microscopy system (Zeiss). Wound closure was quantified at the indicated time points using ImageJ software (National Institutes of Health \[NIH\]) calculated as percent reduction of cell-free surface area compared with immediately after wounding (*t* = 0).

For in vivo biopsy-based mucosal wound model, a high-resolution video endoscope (Coloview Veterinary Endoscope, Karl Storz) equipped with biopsy forceps was used to create biopsy-induced injury of the colonic mucosa at three to five sites along the dorsal aspect of the colon of anesthetized mice (i.p. injection of ketamine 100 mg/kg, xylazine 5 mg/kg). Wound healing was quantified at 24 and 72 h after injury. Endoscopic procedures were viewed with high-resolution (1024 × 768 pixels) images on a flat-panel color monitor. Each wound region was photographed at 24 and 72 h, and wound areas calculated using ImageJ. In each experiment, three to five wounds per mouse were quantified ([@B56]). For IF analysis, wounds were harvested from colons by punch biopsy, embedded, and flash-frozen in OCT embedding compound, followed by sectioning (6 μm thick) and stained as indicated.

IF
--

Samples of human colonic mucosa from individuals with UC or normal mucosa adjacent to colon cancer resections were collected anonymously under approved human subject guidelines at the University of Michigan. All the patients diagnosed with UC exhibited chronic UC with active inflammation. Frozen tissue sections (6 μm thick) of human samples or mouse colons (untreated or treated with DSS) were fixed at room temperature in 4% paraformaldehyde, followed by blocking and permeabilization with 3% bovine serum albumin (BSA)/0.5% Triton X-100 in phosphate-buffered saline (PBS). Primary antibodies were incubated overnight at 4°C in blocking buffer (3% BSA in PBS), followed by fluorescent secondary antibodies (Invitrogen; 1/500) at room temperature for 1 h. DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride) (D1306, Invitrogen) was used to stain nuclei. Slides were washed and mounted with ProLong Antifade Reagent (Thermo Fisher Scientific) prior to analysis as indicated. Fluorescence imaging was performed on a Nikon A1 confocal microscope (Nikon, Tokyo, Japan) in the Microscopy and Image Analysis Laboratory core of the University of Michigan.

Immunoblotting
--------------

Western blotting for cell lines and human and mouse colonic tissue homogenates were performed as described previously ([@B77]). Cells were lysed in RIPA buffer (20 mM Tris-base, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA \[egtazic acid, calcium chelator\], 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, pH 7.4) containing protease and phosphatase inhibitor cocktails (Sigma-Aldrich). Whole colon tissue (mouse or human) was homogenized using a homogenizer in RIPA buffer. Protein concentration was determined using the Pierce Protein BCA kit according to manufacturer's protocol. Samples were boiled for 5 min at 100°C in NuPAGE LDS Sample Buffer (Life Technologies; Eugene, OR) with a final concentration of 100 mM ­dithiothreitol (DTT) (Sigma-Aldrich). Equal quantities of protein samples were loaded into 8% polyacrylamide gels for SDS--PAGE and transferred to polyvinylidene fluoride (PVDF) membrane. Membranes were blocked with either 5% dry milk/Tris-buffered saline \[TBS\]/0.1% Tween-20 or 3% BSA/TBS/0.1% Tween-20 for phosphorylated proteins, followed by overnight incubation with primary antibodies at 4°C. Membranes were then incubated with appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature, followed by development using Clarity Western ECL Substrate and image capture by ChemiDoc imager (Bio-Rad).

Traction force measurements
---------------------------

Traction force measurements were performed as previously described ([@B14]). In brief, elastomeric micropost arrays were fabricated using PDMS replica molding. To make microfabricated post array templates, 1:10 PDMS prepolymer was cast on top of silanized mPAD device silicon masters, cured at 110°C for 30 min, peeled off gently, oxidized with oxygen plasma (Plasma-Preen; Terra Universal), and silanized overnight with (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-1-trichlorosilane (Sigma-Aldrich) vapor under vacuum. To make the final PDMS mPAD device, 1:10 PDMS prepolymer was cast on the template, degassed under vacuum for 20 min, and cured at 110°C for 20 h and gently peeled off the template on a 25-mm-diameter \#1 circular coverslip (Electron Microscopy Services). Peeling-induced collapse of the mPADs was rectified by sonication in 100% ethanol, followed by supercritical drying in liquid CO~2~ using a critical point dryer (Samdri-PVT-3D; Tousimis). Flat PDMS stamps were generated by casting 1:20 PDMS prepolymer on flat and silanized silicon wafers. Stamps were coated in a saturating concentration of fibronectin (Thermo Fisher) (50 μg/ml in PBS) and Alexa Fluor 647--labeled fibrinogen (Thermo Fisher) (20 μg/ml in PBS) for 1 h. These stamps were washed in sterile distilled water and dried under a stream of nitrogen gas. Subsequently, fibronectin-coated stamps were placed in contact with surface-oxidized mPAD substrates (UVO-Model 342; Jelight). mPAD substrates were subsequently transferred to a solution of 0.2% Pluronics F127 (Sigma-­Aldrich) for 30 min to prevent nonspecific protein absorption.

SKCO15 or Caco2-BBE cell lines were seeded in growth medium and then allowed to spread overnight. On the next day, mPAD substrates were transferred to a stainless steel coverslip holder (Attoflour Cell Chamber; Invitrogen) for live cell microscopy and placed in a stage top incubator that regulated temperature, humidity, and CO~2~ (Live Cell; Pathology Devices). Confocal images were taken with a Nikon C2-Confocal Module connected to a Nikon Eclipse Ti inverted microscope, using a high magnification objective (Plan Apochromat 60× water immersion VC, N.A. 1.4; Nikon). Post images were captured using a 640-nm laser with a 685/50 filter; the top and bottom of the posts were sequentially imaged. mPAD deflections were analyzed by custom MATLAB code from Jianping Fu's lab (University of Michigan). The resulting force, F, was calculated using Euler-Bernoulli beam theory, in which E, D, L, and δ are the Young's modulus, post diameter, post height, and post deflection, respectively: F = δ (3πED\^4)/(64L\^3).

Rap1 activity assay
-------------------

Rap1 activity assays were performed according to the manufacturer's instructions (Cell BioLabs, Cat. STA-406-1, San Diego, CA) and as described previously ([@B16]). Briefly, migrating SKCO15 cells KD for Dsc2 or control cells were lysed in kit-supplied buffer (400 µl of 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP-40, 10 mM MaCl~2~, 1 mM EDTA, 2% glycerol). Cell lysates were incubated with 40 μl of Ral-GDS agarose beads for 4 h at 4°C to bind active Rap1. The Ral-GDS beads were washed and boiled in 2× SDS sample buffer. Entire samples were then analyzed by immunoblot with detection by Rap1 antibody (Millipore; Cat. 07-916, d:1/2000).

Quantitative PCR (qPCR) analysis of integrin expression
-------------------------------------------------------

RNA samples were prepared from SKCO15 cells (KD for Dsc2 or control cells) using RNeasy kit (QIAGEN). cDNA was synthesized with iScript cDNA synthesis kit (Bio-Rad). RNA levels of integrin beta1, beta 4, alpha 2, and alpha 6 were determined by qPCR using iQ SYBR Green Supermix (Bio-Rad) with various cycles at 95°C for 10 s and 60°C for 30 s on an CFX connect Real-Time System (Bio-Rad). The primers sequence was: GGATTCTCCAGAAGGTGGTTTCG and TGCCACCAAGTTTCCCATCTCC for integrin beta1, GCAGCTTCCAAATCACAGAGG and CCAGATCATCGGACATGGAGTT for beta 4, GGAACGGGACTTTCGCAT and GGTACTTCGGCTTTCTCATCA for alpha 2, ATGCACGCGGATCGAGTTT and TTCCTGCTTCGTATTAACATGCT for alpha 6, and AATCCCATCACCATCTTCCA and TGGACTCCACGACGTACTCA for GAPDH. Integrin beta1, beta 4, alpha 2, or alpha 6 to GAPDH relative expression was calculated using the 2(^--ΔΔCt^) method and the fold change was calculated by comparing the values to those obtained on control.

Statistics
----------

Statistical significance was measured by Student's *t* test; one-way or two-way analysis of variance (ANOVA) using Graphpad Prism software. Significance was set as *p* ≤ 0.05. Results are expressed as mean ± SEM.
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